Shenzhen Kaifa Technology
920029
Shanghai Yongli Belting
300230
Guomai Culture & Media
301052
4
WuHan Hvsen Biotechnology
300871
5
CHANGFU CO.,LTD
871396
CN Stock MarketDetailed Quotes
601162 Tianfeng
- 4.26
- -0.01-0.23%
Market Closed Mar 28 15:00 CST
36.92BMarket Cap-56.80P/E (TTM)
4.29High4.24Low1.28MlotVolume4.27Open4.27Pre Close545.66MTurnover1.48%Turnover Ratio121.71P/E (Static)8.67BShares6.5052wk High1.60P/B36.92BFloat Cap2.1052wk Low4.70Limit Up8.67BShs Float10.44Historical High3.84Limit Down1.17%Amplitude2.10Historical Low--Dividend TTM4.27Avg Price655.10KlotAsk--Div YieldTTM100Lot Size603.16KlotBid
Tianfeng News
Tianfeng: Differentiated products, channel expansion, and competitive pricing help improve Bruker's market share.
Tianfeng published a Research Report stating that Bluku (00325) is expected to continuously gain market share through differentiated product layout, ongoing extensive expansion of distribution and KA channels, and very competitive pricing. Firstly, from the perspective of brands, the brands involving Transformers action figures on Amazon in the USA include Hasbro (and its children's brand Playskool), LEGO, threezeo, YOLOPARK, JADAToyes, Super7, and other brands; in terms of categories, most brands are focused on action figures, while Bluku's core building toy product layout shows uniqueness and rarity; finally
Tianfeng Securities to Raise 4 Billion Yuan From Share Issuance; Shares Up 3%
Tianfeng: Maintains XINYI SOLAR "Buy" rating, continues to be bullish on the company's growth prospects and leading advantages.
Tianfeng released a Research Report stating that it maintains a "Buy" rating for XINYI SOLAR (00968) and continues to be Bullish on the company's growth prospects and leadership advantages. Considering the current situation of Photovoltaic Glass and raw material prices, the assumptions for Photovoltaic Glass prices and costs have been adjusted. At the same time, taking into account the pace of new capacity deployment by the company, the overall revenue forecast for 2025 and 2026 has been reduced to 22.7/25.1 billion yuan (previously 42.4/50.1 billion Hong Kong dollars, the company has changed its financial report unit from Hong Kong dollars to yuan this year), with a new forecast for 2027 at 27 billion yuan. Additionally, the forecast for net profit attributable to the parent company for 2025 and 2026 has been adjusted down to 1.8/2.5 billion yuan (previously 59.
Tianfeng: The Gold jewelry Industry is currently undergoing a significant transformation cycle. It is recommended to pay attention to old gold shops and others.
Tianfeng released a Research Report stating that the demand for the domestic Gold jewelry industry is generally stable in 2024. The exceptional growth of Lao Pu Gold (06181), far exceeding industry levels, reflects changes in the medium to long-term logic of the industry. The industry is undergoing a major shift from a channel-driven model to a product upgrade-driven model. Traditionally, the Gold jewelry industry relied on channel expansion as its driving force, with a high degree of product homogeneity. As channel dividends diminish, the industry's growth momentum is now shifting from channels to product upgrades, with companies offering higher product differentiation standing out first. The main viewpoints from Tianfeng are as follows: Lao Pu Gold 2.
Tianfeng: Maintains YUE YUEN IND "Buy" rating, optimistic trend for orders in 2025.
Tianfeng Securities released a research report stating that based on the steady growth of YUE YUEN IND (00551), strong performance is expected in 2025, maintaining a "Buy" rating for the company. As Orders further normalize, the demand for high-quality suppliers in the company's Global footwear industry is expected to remain robust. Therefore, the bank maintains its profit forecast, expecting the company's income to be 8.18 billion USD, 9.11 billion USD, and 10.33 billion USD for 2024-2026 respectively; net profit attributable to parent company to be 0.43 billion USD, 0.5 billion USD, and 0.58 billion USD respectively; corresponding EPS to be 0.27 USD/share, 0.31 USD/share, and 0.30 USD/share.
Tianfeng (601162.SH): The company has not connected to Doubao.
On February 14, GeLonghui reported that Tianfeng (601162.SH) stated on the interactive platform that the company has not connected to Doubao.
Tianfeng Securities (SHSE:601162) Shareholder Returns Have Been Decent, Earning 65% in 1 Year
Tianfeng: Maintains the Buy rating for Ideal Autos-W with a Target Price of 141.5 Hong Kong dollars.
Tianfeng Securities issued a research report stating that it maintains a "Buy" rating for Li Auto-W (02015). Considering the company's leading performance in Asia Vets and the new electric product lineup bringing a new growth cycle, a Target Price of HKD 141.5 is set. The firm forecasts the group's annual revenue for 2024 to 2026 to be 1, 47.6 billion, 2, 1.9 billion, and 2, 51.8 billion RMB, with Net income of 8.6 billion, 14.9 billion, and 18.6 billion RMB respectively. The report states that Li Auto's Asia Vets may redefine new luxury. With leading automakers beginning end-to-end PUSH and parking space to parking space, as well as L3.
Tianfeng: Initiates a "Shareholding" rating for STELLA HOLDINGS with a Target Price of 19.60 Hong Kong dollars.
Tianfeng released a Research Report stating that STELLA HOLDINGS (01836) has been given a “Shareholding” rating, corresponding to a Target Price of $2.52 (18.24 yuan, 19.60 HKD). It is expected that the company's revenue for 2024-2026 will be 1.62/1.76/1.92 billion USD (11.7/12.7/13.9 billion yuan), with net income for the parent company projected to be 0.17/0.19/0.21 billion USD (1.3/1.4/1.5 billion yuan), corresponding to a Target Market Cap of 2.1 billion USD (15 billion yuan). Tianfeng's main views are as follows: a global leading developer and manufacturer of footwear, with a long history of stable Operation and a high dividend payout.
Tianfeng Securities Issues Mixed Outlook for 2024; Shares Down 4%
Tianfeng Securities Co., Ltd. 2024 Annual Results Forecast
Sinophorus Offers 100 Million Shares in Shanghai IPO
Tianfeng: Maintaining SMOORE INTL's "Buy" rating and being bullish on the growth potential of the HNB new business.
Tianfeng released a research report stating that, based on the company's Technology and leading advantages, it maintains a "Buy" rating for SMOORE INTL (06969), expecting the company's Net income for 2024-2026 to be 1.609/1.966/2.494 billion yuan, with year-on-year changes of -2.19%/+22.19%/+26.85%. The firm believes that as a global leader in providing atomization Technology solutions, the company's barrier advantages are becoming more pronounced, and under the backdrop of increasingly stringent regulations, the concentration of the Industry Chain is expected to accelerate. Tianfeng's main points are as follows: the company released a revised announcement of the Stock-based Incentive plan, with performance objectives...
Tianfeng: Maintain KUAISHOU-W 'Buy' rating and suggest keeping an eye on the company's profit margin changes.
Tianfeng published a research report stating that, considering the advertising growth of KUAISHOU-W (01024) exceeds expectations, the company is projected to have revenues of 127.1/140.7 billion yuan for 2024-2025; the firm expects the company's adjusted net income for 2024-2025 to be 17.6/21.6 billion yuan, maintaining a "Buy" rating. In Q3 2024, the company achieved revenues of 31.1 billion yuan, with adjusted net income of 3.9 billion yuan and gross profit of 16.9 billion yuan. The firm believes the company's core business revenue is growing steadily and recommends continuous attention to changes in the company's profit margins. Tianfeng's main points are as follows: Flow
Tianfeng Securities Co., Ltd. (SHSE:601162) Stock Most Popular Amongst Retail Investors Who Own 59%, While Private Companies Hold 27%
Tianfeng: Maintain CTIHK's "Buy" rating, expected to become a direct beneficiary of Industry development and transformation.
Tianfeng released a research report stating that it maintains a "Buy" rating for CTIHK (06055), believing that the company, backed by the China Tobacco Group, has significant competitive advantages. It is currently the only overseas capital operation and international business expansion platform under China Tobacco, making it a rare entity and expected to become a direct beneficiary of the development and transformation of the Tobacco industry in China. The company forecasts its net income for 2024/25/26 to be 0.787/0.91/1.1 billion Hong Kong dollars; the company is the only international business platform within the China Tobacco system. The company issued a positive profit forecast, expecting that the profit attributable to owners for the full year of 2024 will increase by no less than 30% year-on-year.
Tianfeng Securities: Initiating coverage with a "Buy" rating for Chabaidao.
Recently, Tianfeng Securities initiated coverage on Cha Baidao (02555), assigning it a "Buy" rating. The report states that in terms of product capability, Cha Baidao's product matrix combines classic and seasonal limited products, leading the market with high cost performance; in terms of business model, the company's main source of income is from franchising, aiming for a more stable revenue source. Due to strict selection, only about 7% of candidates can become franchisees; in terms of supply chain, Cha Baidao continues to invest in supply chain construction. The firm expects that as supply chain efficiency improves and transportation costs are optimized, material costs will be effectively controlled, enhancing Cha Baidao's future gross profit.
Tianfeng: Maintains YUE YUEN IND ‘Buy’ rating with positive growth continuing in manufacturing in November.
Tianfeng released a research report stating that it maintains a "Buy" rating for YUE YUEN IND (00551), expecting the company's revenue for FY24-26 to be $8.65/9.65/10.94 billion, respectively; net profit attributable to parent company is expected to be $0.46/0.54/0.62 billion, respectively; and corresponding EPS is expected to be $0.28/0.33/0.38 per share, respectively. The company's revenue in November 2024 was $0.68 billion, a year-on-year increase of 7.5%, with cumulative revenue of $7.5 billion, a year-on-year increase of 3.4%. The main points from Tianfeng are as follows: The company released November data indicating that revenue from its manufacturing business in 2024 saw a year-on-year growth.
tianfeng Securities: Initiates Coverage on Kelun Botai Biomedical-B with a "shareholding" rating. Enhanced Commercialization Certainty.
Tianfeng released a research report stating that it has initiated coverage of Kelun Biotechnology-B (06990) with a "shareholding" rating. It forecasts the company's revenue for 2024-2026 to be 1.217 billion yuan, 1.654 billion yuan, and 2.476 billion yuan respectively; the net income attributable to the parent company is expected to be -0.72 billion yuan, -0.606 billion yuan, and -0.415 billion yuan. Considering the company's advantages in the ADC technology platform, substantial market space for core products, and promising overseas prospects, the company is viewed as bullish for development. The main viewpoints from Tianfeng are as follows: the ADC self-research capabilities are outstanding, with global research being advanced by Merck, and the certainty of commercialization is strengthened.
Tianfeng Securities: Ideal autos - W3-4Q fundamentals are gradually trending upwards with the expectation of recovery. The continuous improvement of store and infrastructure layout.
Tianfeng Securities released a research report stating that the bank believes that extreme emotions of concern about domestic consumption at the trade level have been digested in Q3. In fact, auto consumption saw a slight recovery in July driven by the policies of replacing old cars with new ones. The continuity of market demand thereafter is indeed difficult to determine, but the underlying fundamentals of Ideal Auto-W (02015) are expected to gradually improve in 3-4Q, and the bank predicts that the development of smart driving technology is expected to drive growth in vehicle value/gross margin.